In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...

The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.

We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

SEKISUI Diagnostics is a well-known provider of many rapid diagnostic solutions to the professional and home testing markets ...

Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...

NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...